International organizations warned on Friday of a potential resurgence of Ebola in Congo after deadly militia attacks on health centers forced aid groups to suspend operations and withdraw staff.
US drug maker Merck & Co Inc has received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.
Some 100 people have died in the Ebola epidemic in DR Congo over the past three weeks, taking the overall death toll in the latest outbreak past 700, according to health ministry data.
Scientists working on developing vaccines against Ebola have found they can “harvest” antibodies from volunteers vaccinated in research trials and use them to make treatments for the deadly viral infection.
Uganda has vaccinated thousands of health workers against Ebola to counter the spread of the deadly virus from its neighbour Democratic Republic of Congo(DRC), says the health ministers of both countries.